Epac/Rap1 inhibit endothelial cell chemotaxis and angiogenesis via induction of Thrombospondin-1

Authors

Robert C. Doebele, University of ColoradoFollow
Frank Thilo Schulze-Hoepfner, Northwestern University
Alexandre Chlenski, University of ChicagoFollow
Kushboo Goel, University of Arizona, Department of MedicineFollow
Jia Hong, University of Chicago
Yuru Liu, University of ChicagoFollow
Mark K. Abe, University of ChicagoFollow
Mark W. Lingen, University of ChicagoFollow
Benjamin David Zeitlin, University of the PacificFollow
Jacques E. Nör, University of Michigan School of DentistryFollow
Marsha Rich Rosner, University of ChicagoFollow

ORCiD

Dr. Benjamin D. Zeitlin: 0000-0003-0110-0188

Department

Biomedical Sciences

Document Type

Conference Presentation

Conference Title

Keystone Symposia on Angiogenesis

Location

Vancouver, British Columbia Canada

Conference Dates

January 15-20, 2008

Date of Presentation

1-19-2008

Comments

Conference Program: https://www.keystonesymposia.org/index.cfm?e=web.meeting.program&meetingid=916

Recommended Citation

Doebele, R. C., Schulze-Hoepfner, F. T., Chlenski, A., Goel, K., Hong, J., Liu, Y., Abe, M. K., Lingen, M. W., Zeitlin, B. D., Nör, J. E., & Rosner, M. R. (2008). Epac/Rap1 inhibit endothelial cell chemotaxis and angiogenesis via induction of Thrombospondin-1. Paper presented at Keystone Symposia on Angiogenesis in Vancouver, British Columbia Canada.
https://scholarlycommons.pacific.edu/dugoni-facpres/88